P

Inventor

XU ZHIWEN

CN19 patents
⚠️ This page may combine multiple inventors who share the name “XU ZHIWEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ATYR PHARMA INC

13 patents
US9605265B2Mar 28, 2017

Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities

ATYR PHARMA INC10 citations92
US8753638B2Jun 17, 2014

Compositions and methods comprising histidyl-TRNA synthetase splice variants having non-canonical biological activities

ATYR PHARMA INC22 citations92
US11078299B2Aug 3, 2021

Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities

ATYR PHARMA INC4 citations84
US10941214B2Mar 9, 2021

Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities

ATYR PHARMA INC3 citations84
US10526419B2Jan 7, 2020

Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities

ATYR PHARMA INC6 citations84
US10017582B2Jul 10, 2018

Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities

ATYR PHARMA INC7 citations84
US9687533B2Jun 27, 2017

Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetases

ATYR PHARMA INC2 citations73
US11807687B2Nov 7, 2023

Therapeutic compositions comprising anti-NRP2 antibodies

ATYR PHARMA INC2 citations69
US11505610B2Nov 22, 2022

Compositions and methods comprising anti-NRP2 antibodies

ATYR PHARMA INC3 citations65
US12497466B2Dec 16, 2025

Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities

ATYR PHARMA INC0 citations62
US12410253B2Sep 9, 2025

Compositions comprising anti-NRP2 antibodies

ATYR PHARMA INC0 citations59
US12065495B2Aug 20, 2024

Compositions and methods comprising anti-NRP2 antibodies

ATYR PHARMA INC1 citations53
US10220080B2Mar 5, 2019

Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetases

ATYR PHARMA INC0 citations52

BEIJING XIAOMI MOBILE SOFTWARE CO LTD

3 patents

ZHOU JIE

1 patent

GREENE LESLIE ANN

1 patent

XU ZHIWEN

1 patent